Top Sell
| Wertpapier | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Omnicell Inc. | 3 | 2 | 0 | 0 | 23,60 € | 35,45 € | 50,23 % |
| Revance Therapeutics Inc. | 0 | 2 | 0 | 0 | 2,58 € | - | - |
| Nevro Corp. | 3 | 2 | 0 | 0 | 7,70 € | 30,29 € | 293,43 % |
| Bruker Corp. | 9 | 2 | 0 | 1 | 56,52 € | 83,44 € | 47,63 % |
| Agenus Inc. | 5 | 2 | 2 | 0 | 0,41 € | 36,85 € | 8804,78 % |
| Coherus Bioscien. | 1 | 2 | 0 | 0 | 1,36 € | - | - |
| Anavex Life Sciences Corp | 1 | 2 | 1 | 0 | 4,05 € | 5,50 € | 35,67 % |
| Owens & Minor Inc. | 2 | 2 | 0 | 1 | 11,60 € | 25,05 € | 115,96 % |
| Karyopharm Therapeutics Inc. | 10 | 2 | 1 | 0 | 0,76 € | 6,95 € | 812,83 % |
| Fibrogen Inc. | 1 | 3 | 1 | 1 | 0,72 € | 10,00 € | 1292,76 % |
| Akebia Therapeutics Inc. | 7 | 3 | 0 | 1 | 0,87 € | 3,60 € | 312,74 % |
| Integra LifeSciences Holdings Corp | 3 | 3 | 0 | 0 | 26,60 € | 34,68 € | 30,37 % |
| Elanco Animal Health Inc. | 8 | 3 | 1 | 0 | 12,28 € | 15,66 € | 27,54 % |
| Fate Therapeutics Inc. | 3 | 3 | 1 | 0 | 2,91 € | 7,31 € | 151,39 % |
| Glycomimetics Inc. | 5 | 3 | 0 | 3 | 0,26 € | 7,35 € | 2782,98 % |
| Bristol-Myers Squibb | 11 | 3 | 1 | 0 | 37,83 € | 70,67 € | 86,80 % |
| Immunic Inc. | 5 | 3 | 0 | 0 | 1,20 € | 6,43 € | 436,08 % |
| Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | 7,45 € | 58,50 € | 685,23 % |
| Atara Biotherapeutics Inc. | 2 | 4 | 0 | 1 | 0,37 € | 1,60 € | 335,49 % |
| Sage Therapeutics Inc. | 7 | 4 | 2 | 0 | 10,58 € | 26,21 € | 147,80 % |
| Avinger Inc. | 2 | 4 | 0 | 0 | 0,34 € | 4,64 € | 1272,63 % |
| Cardiff Oncology Inc. | 2 | 4 | 0 | 0 | 2,02 € | 5,00 € | 147,52 % |
| Palatin Technologies Inc. | 0 | 4 | 0 | 0 | 1,64 € | - | - |
| Pacific Biosciences of California Inc. | 9 | 5 | 0 | 0 | 1,22 € | 9,62 € | 688,33 % |
| Waters Corp. | 0 | 5 | 0 | 1 | 264,50 € | 256,55 € | -3,01 % |